论文部分内容阅读
AIM: To investigate the reduction in hepatitis B virus(HBV) covalently closed-circular DNA (cccDNA) withentecavir (ETV) or lamivudine (LAM).METHODS: This analysis included patients who hadparticipated in the randomized Phase Ⅲ study ETV-022comparing ETV v